Endocarditis is inflammation of the inside lining of the heart chambers and heart valves (endocardium). It is caused by a bacterial or, rarely a fungal infection.
Endocarditis can involve the heart muscle, heart valves, or lining of the heart. Some people who develop endocarditis have a:
- Birth defect of the heart
- Damaged or abnormal heart valve
- History of endocarditis
- New heart valve after surgery
- Parenteral (intravenous) drug addiction
- Long-term intravenous line in place
Endocarditis begins when germs enter the bloodstream and then travel to the heart.
- Bacterial infection is the most common cause of endocarditis.
- Endocarditis can also be caused by fungi, such as Candida.
- In some cases, no cause can be found.
Germs are most likely to enter the bloodstream during:
- Central venous access lines
- Injection drug use, from the use of unclean (unsterile) needles
- Recent dental surgery
- Other surgeries or minor procedures to the breathing tract, urinary tract, infected skin, or bones and muscles
Symptoms of endocarditis may develop slowly or suddenly.
- Be present for days before any other symptoms appear
- Come and go, or be more noticeable at nighttime
Other signs can include:
Exams and Tests
The health care provider may detect a new heart murmur, or a change in a past heart murmur.
An eye exam may show bleeding in the retina and a central area of clearing. This finding is known as Roth spots. There may be small, pinpoint areas of bleeding on the surface of the eye or the eyelids.
Tests that may be done include:
You may need to be in hospital to get antibiotics through a vein (IV or intravenously). Blood cultures and tests will help your provider choose the best antibiotic.
You will then need long-term antibiotic therapy.
- People most often need therapy for 4 to 6 weeks to kill all the bacteria from the heart chambers and valves.
- Antibiotic treatments that are started in the hospital will need to be continued at home.
Surgery to replace the heart valve is often needed when:
- The infection is breaking off in little pieces, resulting in strokes.
- The person develops heart failure as a result of damaged heart valves.
- There is evidence of more severe organ damage (such as heart damage).
Getting treatment for endocarditis right away improves the chances of a good outcome.
More serious problems that may develop include:
The American Heart Association recommends preventive antibiotics for people at risk for infectious endocarditis, such as those with:
- Certain birth defects of the heart
- Heart transplant and valve problems
- Prosthetic heart valves (heart valves inserted by a surgeon)
- Past history of endocarditis
These people should receive antibiotics when they have:
- Dental procedures that are likely to cause bleeding
- Procedures involving the breathing tract
- Procedures involving the urinary tract system
- Procedures involving the digestive tract
- Procedures on skin infections and soft tissue infections
Valve infection; Staphylococcus aureus - endocarditis; Enterococcus - endocarditis; Streptococcus viridans - endocarditis; Candida - endocarditis
Baddour LM, Freeman WK, Suri RM, Wilson WR. Cardiovascular infections. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 73.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-1486. PMID: 26373316 www.ncbi.nlm.nih.gov/pubmed/26373316.
Fowler VG, Bayer AS, Baddour LM. Infective endocarditis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 67.
Holland TL, Bayer AS, Fowler VG. Endocarditis and intravascular infections. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 80.
Review Date 12/24/2020
Updated by: Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA.Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.